Francesco Menichetti

Best Publications

• Effect and Safety of Meropenem–Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial

  Richard G. Wunderink;Evangelos J. Giamarellos-Bourboulis;Galia Rahav;Amy J. Mathers

  416
  Citations

• Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by Klebsiella pneumoniae Carbapenemase-producing K. pneumoniae.

  Mario Tumbarello;Enrico Maria Trecarichi;Alberto Corona;Francesco Giuseppe De Rosa

  363
  Citations

• Efficacy of Ceftazidime-avibactam Plus Aztreonam in Patients With Bloodstream Infections Caused by Metallo-β-lactamase–Producing Enterobacterales

  Marco Falcone;George L Daikos;Giusy Tiseo;Dimitrios Bassoulis

  353
  Citations

• Itraconazole Oral Solution as Prophylaxis for Fungal Infections in Neutropenic Patients with Hematologic Malignancies: A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial

  Menichetti F;Del Favero A;Martino P;Bucaneve G

  344
  Citations

• A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality

  Matteo Bassetti;Elda Righi;Filippo Ansaldi;Maria Merelli

  256
  Citations

• A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts

  Matteo Bassetti;Monia Marchetti;Arunaloke Chakrabarti;Sergio Colizza

  247
  Citations

• Current and emerging serious Gram-positive infections

  Unknown

  241
  Citations

• Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial

  Benoit Guery;Francesco Menichetti;Veli-Jukka Anttila;Nicholas Adomakoh

  220
  Citations

• Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria

  Matteo Bassetti;Jan J. De Waele;Philippe Eggimann;Josè Garnacho-Montero

  207
  Citations

• Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae.

  Marco Falcone;Matteo Bassetti;Giusy Tiseo;Cesira Giordano

  194
  Citations

• Cefiderocol- Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii

  Unknown

  176
  Citations

• Preventing Fungal Infection in Neutropenic Patients with Acute Leukemia: Fluconazole Compared with Oral Amphotericin B

  Francesco Menichetti;Albano Del Favero;Piero Martino;Giampaolo Bucaneve

  176
  Citations

• Microbiology of cardiac implantable electronic device infections.

  Unknown

  176
  Citations

• mcr-1.2, a New mcr Variant Carried on a Transferable Plasmid from a Colistin-Resistant KPC Carbapenemase-Producing Klebsiella pneumoniae Strain of Sequence Type 512.

  Vincenzo Di Pilato;Fabio Arena;Carlo Tascini;Antonio Cannatelli

  175
  Citations

• Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections

  Alessandro Russo;E. Concia;Francesco Cristini;F. G. De Rosa

  168
  Citations

• Synergistic activity of colistin plus rifampin against colistin-resistant kpc-producing klebsiella pneumoniae

  Carlo Tascini;Enrico Tagliaferri;Tommaso Giani;Alessandro Leonildi

  163
  Citations

• Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience.

  Matteo Bassetti;Nadia Castaldo;Annamaria Cattelan;Cristina Mussini

  156
  Citations

• Ceftolozane/tazobactam: place in therapy.

  Daniele Roberto Giacobbe;Matteo Bassetti;Francesco Giuseppe De Rosa;Valerio Del Bono

  138
  Citations

• Carbapenem-Sparing Antibiotic Regimens for Infections Caused by Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae in Intensive Care Unit

  Unknown

  137
  Citations

• High-Dose Fluconazole Therapy for Cryptococcal Meningitis in Patients with AIDS

  Unknown

  131
  Citations